Study Summary
This trial will test three different treatments for metabolic issues in US residents. Participants will be randomly assigned to one of the three groups, and will be surveyed at the beginning and end of the trial. The trial will not be conducted at clinical sites.
Treatment Effectiveness
Phase-Based Effectiveness
N/A
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: ~4months
~4 months
Efficacy of VIOME Precision Nutrition Program (VPNP)
~4months
Efficacy of VIOME's designed condition based supplements (VCS)
Trial Safety
Phase-Based Safety
Awards & Highlights
No Placebo Group
All patients enrolled in this trial will receive the new treatment.
Trial Design
3 Treatment Groups
Viome's Precision Nutrition Program
1 of 3
Viome's condition-based supplements
1 of 3
Placebo
1 of 3
Active Control
150 Total Participants · 3 Treatment Groups
Primary Treatment: Viome's Precision Nutrition Program · No Placebo Group · N/A
Viome's Precision Nutrition Program
CombinationProduct
ActiveComparator Group · 1 Intervention: VIOME Precision Nutrition Program · Intervention Types: CombinationProductViome's condition-based supplements
DietarySupplement
ActiveComparator Group · 1 Intervention: VIOME-designed condition-based supplements · Intervention Types: DietarySupplementPlaceboNoIntervention Group · 1 Intervention: Placebo · Intervention Types:
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: ~4months
Who is running the clinical trial?
ViomeLead Sponsor
15 Previous Clinical Trials
117,505 Total Patients Enrolled
Momchilo VuyisichPrincipal InvestigatorViome Life Sciences
8 Previous Clinical Trials
103,730 Total Patients Enrolled
Eligibility Criteria
Age 25 - 75 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You do not have unexplained weight loss, fevers, anemia, or blood in your stool.